The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP 1 medications, GLP1 and progress doses Agent Frequency Titration Schedule Weekly Dulaglutide Semaglutide Liraglutide 4 week Equivalent Doses Weekly 4 week 0.75 mg Daily 1.5 mg 1 week Oral Semaglutide Tirzepatide 0.25 mg 3 Your guide to GLP 1 side effects WW USA GLP 1s: Impact on Health Costs & Cardiodiabesity Evernorth Orlistat Capsules Weight Loss Tablets UK EverydayMeds EveryDayMeds MHRA grants authorisation for Lilly's weight loss drug Mounjaro